Stimulation of brain cannabinoid CB1 receptors can ameliorate hypertension in spontaneously hypertensive rats.

Clinical and Experimental Pharmacology & Physiology
Takahiro ShimizuMotoaki Saito

Abstract

Excessive activation of the sympatho-adrenomedullary system plays a pathogenic role in triggering and sustaining essential hypertension. We previously reported that, in normotensive rats, intracerebroventricularly (i.c.v.) administered neuropeptides, corticotropin-releasing factor and bombesin induced activation of the sympatho-adrenomedullary system, and that brain cannabinoid CB1 receptors negatively regulated this activation. In this study, we investigated the effects of brain CB1 receptor stimulation on blood pressure and the sympatho-adrenomedullary outflow in spontaneously hypertensive rats (SHRs), commonly used animal models of essential hypertension, and in Wistar-Kyoto (WKY) rats, normotensive controls of SHRs. In 18-week-old SHRs and WKY rats under urethane anaesthesia (1.0 g/kg, i.p.), SHRs exhibited significantly higher systolic, mean and diastolic blood pressures and plasma noradrenaline and adrenaline, and a lower heart rate than WKY rats. Single administration of arachidonyl 2'-chloroethylamide (ACEA, CB1 agonist, 1.4 µmol/animal, i.c.v.) significantly but partially reduced mean and diastolic blood pressures and the plasma level of noradrenaline in SHRs compared to vehicle (N,N-dimethylformamide)-treated SHRs. Th...Continue Reading

References

Oct 1, 1994·Clinical and Experimental Pharmacology & Physiology·G A Head
Apr 8, 1998·The American Journal of Physiology·J G Dickhout, R M Lee
Nov 13, 2001·British Journal of Pharmacology·N NiederhofferB Szabo
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·M EslerG Lambert
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Jun 1, 2002·Metabolism: Clinical and Experimental·Theodore B Vanitallie
Oct 22, 2003·Physiology & Behavior·Alessandro BartolomucciAndrea Sgoifo
Nov 15, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Jeanne L SeagardCecilia J Hillard
May 29, 2004·Neuroreport·Carmen ManzanedoJosé Miñarro
Sep 15, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Harold Kalant
Oct 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·De-Pei Li, Hui-Lin Pan
Nov 18, 2005·Autonomic Neuroscience : Basic & Clinical·Stuart J McDougallAndrew J Lawrence
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maria EllgrenYasmin L Hurd
Oct 24, 2007·Molecular Neurobiology·Roger G Pertwee
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrea S HeimannLakshmi A Devi
Apr 16, 2009·International Review of Psychiatry·Chris S Breivogel, Laura J Sim-Selley
Apr 22, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ivone GomesLakshmi A Devi
May 27, 2009·Nature Reviews. Neuroscience·Yvonne M Ulrich-Lai, James P Herman
Jun 12, 2009·Journal of Hypertension·Murray Esler
Dec 17, 2009·Experimental Physiology·Guido GrassiFosca Quarti-Trevano
Mar 4, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·B MalinowskaE Schlicker
Sep 24, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·C Dean
Apr 2, 2013·Neuropharmacology·Garron T DoddSimon M Luckman
Sep 5, 2013·Nature Communications·Fiona D McBrydeJulian F R Paton
Feb 5, 2014·Brain Research·Marco Antônio Peliky FontesEugene Nalivaiko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.